google-site-verification: googlec7193c3de77668c9.html

Newfound biomarkers may someday help clinicians better detect—and possibly cure—Lyme disease

[
Lyme disease can be easiest to treat in its earliest stages, but current tests often miss infections during that critical window and cannot tell whether bacteria are still present or were cleared years ago. New research led by Tufts University School of Medicine suggests that a group of immune molecules called anti-lipid antibodies may address these shortcomings.


Source link

Advertisements
Views: 1

See also  Diagnosing cancer with a drop of blood

Check Also

New T‑cell therapy targets three tumor proteins, shows early survival gains in aggressive pediatric brain cancers

[ Researchers report encouraging early results from a first-in-human clinical trial led by Children’s National …

Lab-grown retinal cells show promise for new eye therapies

[ Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow …

Kidney cancer gene reveals an unexpected weakness and a new path for treatment

[ Aguirre de Cubas, Ph.D., investigates kidney cancer. Credit: Clif Rhodes A common genetic mutation …

Leave a Reply

Available for Amazon Prime